Lanean...
Pharmacokinetic Interaction between Efavirenz and Dual Protease Inhibitors in Healthy Volunteers
The combination of efavirenz with HIV-1 protease inhibitors (PI) results in complex interactions secondary to mixed induction and inhibition of oxidative metabolism. ACTG A5043 was a prospective, open-label, controlled, two-period, multiple-dose study with 55 healthy volunteers. The objective of the...
Gorde:
| Argitaratua izan da: | Biopharm Drug Dispos |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2008
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4307806/ https://ncbi.nlm.nih.gov/pubmed/18041735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bdd.597 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|